Page last updated: 2024-10-30

loxoprofen and Alzheimer Disease

loxoprofen has been researched along with Alzheimer Disease in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hori, K1
Konishi, K1
Akita, R1
Tanaka, H1
Hachisu, M1

Other Studies

1 other study available for loxoprofen and Alzheimer Disease

ArticleYear
Fluvoxamine and celecoxib may have caused adverse events in an elderly patient.
    Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:5

    Topics: Aged, 80 and over; Alzheimer Disease; Amnesia; Anti-Inflammatory Agents, Non-Steroidal; Antidepressi

2013